Paper75057
Differential sensitivities of five rat hepatoma cell lines to anticancer drugs.
Barranco SC and 2 others. Cancer Res, 1978. Cited by 45 papers, by iCite.
Cite this record
ConductScience Library. Differential sensitivities of five rat hepatoma cell lines to anticancer drugs. Papers, record 75057. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/75057
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| Animals | |
| Bleomycin | |
| Cell Line | |
| Cell Survival | |
| Cytarabine | |
| Doxorubicin | |
| Drug Resistance | |
| Hydroxyurea | |
| Lomustine | |
| Neoplasms, Experimental | |
| Rats | |
| Semustine |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 29930714 | Integrated multi-omics data analysis identifying novel drug sensitivity-associated molecular targets of hepatocellular carcinoma cells. | Oncol Lett | 2018 | https://conductscience.org/library/papers/29930714 | PubMed |
| 7426346 | Colony growth and clonogenic cell survival in human melanoma xenografts treated with chemotherapy. | Br J Cancer | 1980 | https://conductscience.org/library/papers/7426346 | PubMed |
| 6678862 | In vitro cellular characteristics and survival responses of human astrocytoma clones to chloroethyl-nitrosoureas and dianhydrogalactitol. | Invest New Drugs | 1983 | https://conductscience.org/library/papers/6678862 | PubMed |
| 6678861 | Heterogeneous responses of an in vitro model of human stomach cancer to anticancer drugs. | Invest New Drugs | 1983 | https://conductscience.org/library/papers/6678861 | PubMed |
| 6616441 | The selective nature of metastasis. | Cancer Metastasis Rev | 1983 | https://conductscience.org/library/papers/6616441 | PubMed |
| 6453124 | Comparison of cytostatic sensitivities of L 1210 cells and human stimulated lymphocytes in three cell proliferation assays. | J Cancer Res Clin Oncol | 1980 | https://conductscience.org/library/papers/6453124 | PubMed |
| 6242707 | Phenotypic drift and heterogeneity in response of metastatic mammary adenocarcinoma cell clones to adriamycin, 5-fluoro-2'-deoxyuridine and methotrexate treatment in vitro. | Clin Exp Metastasis | 1983 | https://conductscience.org/library/papers/6242707 | PubMed |
| 2578470 | Treatment of human cell lines with 5-azacytidine may result in profound alterations in clonogenicity and growth rate. | J Cell Biol | 1985 | https://conductscience.org/library/papers/2578470 | PubMed |
| 2358741 | Primary and metastatic liver lesions of clinical colorectal cancer differ in chemosensitivity. | Int J Colorectal Dis | 1990 | https://conductscience.org/library/papers/2358741 | PubMed |
| 475962 | Assays of drug sensitivity for cells from human tumours: in vitro and in vivo tests on a xenografted tumour. | Br J Cancer | 1979 | https://conductscience.org/library/papers/475962 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/75057
GET https://conductscience.org/api/papers/v1/75057/authors